CHARLES SIMONE II was named medical director of the Maryland Proton Treatment Center, effective in November. Simone will help define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System and the university’s school of medicine. He will...
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
